30 Day Trial
BARE BONES logo

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Histogenics Update: Agreement with Japan PMDA on NeoCart Regulatory Path -

Histogenics successfully completed consultations with Japan's PMDA regarding the regulatory path for NeoCart® autologous cell therapy for the treatment of knee cartilage defects. (Histogenics Corporation, 5/8/17)